+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Advanced Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cervical Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 160 Pages
  • Global
From
From
From
From
Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2021-2026 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2021-2026

  • Report
  • September 2026
  • 1050 Pages
  • Global
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Collaboration Deals in Pharmaceuticals 2021-2026 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2021-2026

  • Report
  • September 2026
  • 700 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Biologics API Market  - Trends and Forecast Till 2035 - Product Thumbnail Image

Biologics API Market - Trends and Forecast Till 2035

  • Report
  • October 2026
  • 209 Pages
  • Global
From
From
Loading Indicator